Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these receptors, https://laytnyxtt620275.blogs100.com/36753562/tirzepatide-a-promising-new-treatment-for-obesity